Specialization in medical biochemistry in the Republic of North Macedonia-future perspectives
Date Issued
2022
Author(s)
Abstract
Laboratory profession across Europe still differs in academic background of the specialists in clinical chemistry. In our
country, specialists in medical biochemistry/clinical chemistry hold basic education in general medicine (MDs) or pharma-
cy (Ms PHs). The length of the graduate studies in general medicine is six years with 360 ECTS, and the length for general
pharmacy is five years with 300 ECTS. Few common subjects are studied during graduate studies for both profiles that
differ in the ECTS, such as: Chemistry (7 ECTS for MDs and 39,5 ECTS for Ms PHs); Anatomy and physiology (28 ECTS for
MDs and 10 ECTS Ms PHs), Biochemistry (12,5 ECTS for MDs and 6 ECTS for Ms PHs), Biophysics (2 ECTS for MDs and 7
ECTS for Ms PHs), Molecular and Cell Biology and Genetics (10 ECTS for MDs and 6 ECTS for Ms PHs); Microbiology (10
ECTS for MDs and 7 ECTS for Ms PHs); Pathophysiology (11,5 ECTS for MDs and 6 for Ms PH); Pharmacology (7 ECTS for
MDs and 6 for Ms PHs); Clinical Biochemistry (1,5 ECTS for MDs and 7 ECTS for Ms PHs). The postgraduate training in
medical biochemistry, as a monovalent specialization, for both profiles, ranges 4 years. Although the graduate syllabus
in pharmacology doesn’t have any clinical subject, the specialization program for both graduate profiles is the same for
both profiles, as well as the title, and was succeeded and revised several times after the succession of the former country.
Presently, the total length of basic education for both profiles is 10.5 for MDs and 9,5 years respectively, and both profiles
are registered in the European Register of Specialists in Laboratory Medicine. The question arising for the perspective
vocational training for medical doctors and pharmacists is: do we need different specialization programs for these pro-
files, bearing in mind the previous education and the need of our health care system? The opinion of the members of the
Department of Biochemistry and Clinical Chemistry (responsible for proposing and creating specialization syllabuses)
is that, in our country, we need two different monovalent specializations in clinical chemistry/medical biochemistry, one
for medical doctors and one for masters of pharmacy, which will result in two different profiles and responsibilities in the
health care system in our republic.
country, specialists in medical biochemistry/clinical chemistry hold basic education in general medicine (MDs) or pharma-
cy (Ms PHs). The length of the graduate studies in general medicine is six years with 360 ECTS, and the length for general
pharmacy is five years with 300 ECTS. Few common subjects are studied during graduate studies for both profiles that
differ in the ECTS, such as: Chemistry (7 ECTS for MDs and 39,5 ECTS for Ms PHs); Anatomy and physiology (28 ECTS for
MDs and 10 ECTS Ms PHs), Biochemistry (12,5 ECTS for MDs and 6 ECTS for Ms PHs), Biophysics (2 ECTS for MDs and 7
ECTS for Ms PHs), Molecular and Cell Biology and Genetics (10 ECTS for MDs and 6 ECTS for Ms PHs); Microbiology (10
ECTS for MDs and 7 ECTS for Ms PHs); Pathophysiology (11,5 ECTS for MDs and 6 for Ms PH); Pharmacology (7 ECTS for
MDs and 6 for Ms PHs); Clinical Biochemistry (1,5 ECTS for MDs and 7 ECTS for Ms PHs). The postgraduate training in
medical biochemistry, as a monovalent specialization, for both profiles, ranges 4 years. Although the graduate syllabus
in pharmacology doesn’t have any clinical subject, the specialization program for both graduate profiles is the same for
both profiles, as well as the title, and was succeeded and revised several times after the succession of the former country.
Presently, the total length of basic education for both profiles is 10.5 for MDs and 9,5 years respectively, and both profiles
are registered in the European Register of Specialists in Laboratory Medicine. The question arising for the perspective
vocational training for medical doctors and pharmacists is: do we need different specialization programs for these pro-
files, bearing in mind the previous education and the need of our health care system? The opinion of the members of the
Department of Biochemistry and Clinical Chemistry (responsible for proposing and creating specialization syllabuses)
is that, in our country, we need two different monovalent specializations in clinical chemistry/medical biochemistry, one
for medical doctors and one for masters of pharmacy, which will result in two different profiles and responsibilities in the
health care system in our republic.
File(s)![Thumbnail Image]()
Loading...
Name
LM4MS_ABSTRACTS.pdf
Size
2.71 MB
Format
Adobe PDF
Checksum
(MD5):e4774d1cd4ffe1ac55a2689098444005